Femasys Corp (FEMY) - Forward Price-to-Revenue Multiple

Stable system assembly in the US has minimized logistical risks for Femasys Inc. (FEMY). The business's forward P/S reflects current valuation trends, where 5.10 represents the latest metric reading. Growth prospects are based on the implementation of FemaSeed and FemBloc systems. The uniqueness of non-operative diagnostic methods will enable the company to independently determine the pricing power of its innovative products for clinics.

FEMY femasys.com: Forward Price-to-Revenue Multiple in the range 07/04/2022 - 11/13/2026

Femasys Corporation - analytical breakdowns and key metrics (FEMY)

- market price and analyst price targets:

Price Chart Femasys|FEMY - Fair Value Consensus

- market capitalization indicators:

Market Valuation Femasys Corporation|FEMY - Enterprise Value

- business book valuation details:

Net Assets per Single Share Femasys|FEMY - Company Net Assets|Market Capitalization to Book Value Ratio femasys.com|FEMY - Company Assets

- issuer credit burden and liquidity indicators:

- business earnings and investment ratios data:

FEMY - Company Net Income|Expected Profit Femasys Inc.|FEMY - Price to Earnings Ratio|Forward P/E Multiple Femasys Corp|FEMY - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Femasys Corporation|FEMY - Operating income before deduction of amortization|Net earnings per share for the last 12 months Femasys|FEMY - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months femasys.com|FEMY - Expected net earnings per share growth this year|Expected earnings per share growth for next year Femasys Inc.

- sales and revenue data:

FEMY - Company Sales Revenue|Projected Sales Volume Femasys|FEMY - Price-to-Revenue Coefficient|Price-to-Projected Revenue Ratio Femasys Corporation

General company analysis:FEMY (Femasys)

This indicator correlates current market capitalization with projected forward sales for the year, allowing for an assessment of whether the asset is overvalued or undervalued relative to future cash flows. By analyzing the forward price-to-sales ratio, an investor can determine the extent to which the market currently prices in the success of Femasys Inc. (FEMY) organic expansion into the gynecological sector, excluding external acquisitions.

Analysis of competing companies